BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 26070204)

  • 1. Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response.
    Sasaki R; Yamasaki K; Abiru S; Komori A; Nagaoka S; Saeki A; Hashimoto S; Bekki S; Kugiyama Y; Kuno A; Korenaga M; Togayachi A; Ocho M; Mizokami M; Narimatsu H; Ichikawa T; Nakao K; Yatsuhashi H
    PLoS One; 2015; 10(6):e0129053. PubMed ID: 26070204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Hepatocellular Carcinoma Development after Hepatitis C Virus Eradication Using Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein.
    Sato S; Genda T; Ichida T; Amano N; Sato S; Murata A; Tsuzura H; Narita Y; Kanemitsu Y; Hirano K; Shimada Y; Iijima K; Wada R; Nagahara A; Watanabe S
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development.
    Kim SU; Heo JY; Kim BK; Park JY; Kim DY; Han KH; Ahn SH; Kim HS
    Liver Int; 2017 Jun; 37(6):879-887. PubMed ID: 27973711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum WFA(+) -M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C.
    Ura K; Furusyo N; Ogawa E; Hayashi T; Mukae H; Shimizu M; Toyoda K; Murata M; Hayashi J
    Aliment Pharmacol Ther; 2016 Jan; 43(1):114-24. PubMed ID: 26503582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Evaluation of Hepatocarcinogenesis and Outcome Using a Novel Glycobiomarker Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA
    Inoue T; Tsuzuki Y; Iio E; Shinkai N; Matsunami K; Fujiwara K; Matsuura K; Nojiri S; Tanaka Y
    Jpn J Infect Dis; 2018 May; 71(3):177-183. PubMed ID: 29491234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts liver cancer development in chronic hepatitis B patients under antiviral treatment.
    Cheung KS; Seto WK; Wong DK; Mak LY; Lai CL; Yuen MF
    Oncotarget; 2017 Jul; 8(29):47507-47517. PubMed ID: 28537900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum WFA+ -M2BP levels as a prognostic factor in patients with early hepatocellular carcinoma undergoing curative resection.
    Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A; Korenaga M; Mizokami M; Narimatsu H
    Liver Int; 2016 Feb; 36(2):293-301. PubMed ID: 26134114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma.
    Fujiyoshi M; Kuno A; Gotoh M; Fukai M; Yokoo H; Kamachi H; Kamiyama T; Korenaga M; Mizokami M; Narimatsu H; Taketomi A;
    J Gastroenterol; 2015 Nov; 50(11):1134-44. PubMed ID: 25773774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus.
    Heo JY; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Park YN; Ahn SS; Han KH; Kim HS
    Medicine (Baltimore); 2016 Apr; 95(14):e3328. PubMed ID: 27057911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy.
    Nagata H; Nakagawa M; Nishimura-Sakurai Y; Asano Y; Tsunoda T; Miyoshi M; Kaneko S; Goto F; Otani S; Kawai-Kitahata F; Murakawa M; Nitta S; Itsui Y; Azuma S; Kakinuma S; Tojo N; Tohda S; Asahina Y; Watanabe M;
    Hepatol Int; 2016 Nov; 10(6):956-964. PubMed ID: 27435935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis.
    Hasegawa K; Takata R; Nishikawa H; Enomoto H; Ishii A; Iwata Y; Miyamoto Y; Ishii N; Yuri Y; Nakano C; Nishimura T; Yoh K; Aizawa N; Sakai Y; Ikeda N; Takashima T; Iijima H; Nishiguchi S
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27626413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts hepatocellular carcinoma incidence and recurrence in nucleos(t)ide analogue therapy for chronic hepatitis B.
    Kawaguchi K; Honda M; Ohta H; Terashima T; Shimakami T; Arai K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Komura T; Unoura M; Kaneko S
    J Gastroenterol; 2018 Jun; 53(6):740-751. PubMed ID: 28849280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Noninvasive Estimation of Liver Fibrosis and Hepatocellular Carcinoma Development Using WFA(+)-M2BP in Chronic Hepatitis C Patients].
    Tamaki N; Kurosaki M; Izumi N
    Rinsho Byori; 2015 Sep; 63(9):1039-43. PubMed ID: 26731891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein but not α-fetoprotein as a Long-Term Hepatocellular Carcinoma Predictor.
    Osawa L; Tamaki N; Kurosaki M; Kirino S; Watakabe K; Wang W; Okada M; Shimizu T; Higuchi M; Takaura K; Takada H; Kaneko S; Yasui Y; Tsuchiya K; Nakanishi H; Itakura J; Takahashi Y; Enomoto N; Izumi N
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients.
    Yamasaki K; Tateyama M; Abiru S; Komori A; Nagaoka S; Saeki A; Hashimoto S; Sasaki R; Bekki S; Kugiyama Y; Miyazoe Y; Kuno A; Korenaga M; Togayachi A; Ocho M; Mizokami M; Narimatsu H; Yatsuhashi H
    Hepatology; 2014 Nov; 60(5):1563-70. PubMed ID: 25042054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein for patients with chronic hepatitis B and C: a comparative study.
    Nishikawa H; Enomoto H; Iwata Y; Kishino K; Shimono Y; Hasegawa K; Nakano C; Takata R; Nishimura T; Yoh K; Ishii A; Aizawa N; Sakai Y; Ikeda N; Takashima T; Iijima H; Nishiguchi S
    J Viral Hepat; 2016 Dec; 23(12):977-984. PubMed ID: 27476460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Glycomarker for Short-term Prediction of Hepatocellular Carcinoma: A Longitudinal Study With Serial Measurements.
    Lin YJ; Chang CL; Chen LC; Hu HH; Liu J; Korenaga M; Huang YH; Jen CL; Su CY; Nishida N; Sugiyama M; Lu SN; Wang LY; Yuan Y; L'Italien G; Yang HI; Mizokami M; Chen CJ; Lee MH
    Clin Transl Gastroenterol; 2018 Sep; 9(9):183. PubMed ID: 30237482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C.
    Nagata H; Nakagawa M; Asahina Y; Sato A; Asano Y; Tsunoda T; Miyoshi M; Kaneko S; Otani S; Kawai-Kitahata F; Murakawa M; Nitta S; Itsui Y; Azuma S; Kakinuma S; Nouchi T; Sakai H; Tomita M; Watanabe M;
    J Hepatol; 2017 Nov; 67(5):933-939. PubMed ID: 28627363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of serum Wisteria floribunda agglutinin-positive human Mac-2-binding protein as a predictive marker for hepatitis C virus-related complications after systemic chemotherapy.
    Totani H; Kusumoto S; Tanaka Y; Suzuki N; Hagiwara S; Kinoshita S; Iio E; Ito A; Ri M; Ishida T; Komatsu H; Iida S
    Int J Hematol; 2016 Sep; 104(3):384-91. PubMed ID: 27255233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection.
    Kim HS; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Park YN; Han DH; Kim KS; Choi JS; Choi GH; Kim HS
    Clin Mol Hepatol; 2020 Jan; 26(1):33-44. PubMed ID: 31243939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.